Feinstein Institutes secures $6.1M NIH grant for research into red blood cell disorders

The Feinstein Institutes for Medical Research  has been awarded a $6.1 million grant from The National Institutes of Health (NIH) to the to advance knowledge of red cell disorders and to develop better treatments.
Red blood cell disorders, including sickle cell disease (SCD), Diamond-Blackfan anemia (DBA) and other forms of anemia, collectively affect more than 1 billion individuals worldwide and represent a significant cause of chronic illness and mortality.